These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 17667012

  • 1. Combination therapy with new targets in Type 2 diabetes: a review of available agents with a focus on pre-exercise adjustment.
    McDonnell ME.
    J Cardiopulm Rehabil Prev; 2007; 27(4):193-201. PubMed ID: 17667012
    [Abstract] [Full Text] [Related]

  • 2. Therapy for type 2 diabetes mellitus.
    Elson DF, Meredith M.
    WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
    [Abstract] [Full Text] [Related]

  • 3. Treatment of type 2 diabetes: one extreme to another.
    Zaidi S.
    Arch Intern Med; 2009 Jul 13; 169(13):1246-7; author reply 1247. PubMed ID: 19597079
    [No Abstract] [Full Text] [Related]

  • 4. Exploring the pharmacotherapeutic options for treating type 2 diabetes.
    Kruger DF.
    Diabetes Educ; 2008 Jul 13; 34 Suppl 3():60S-65S. PubMed ID: 18525066
    [Abstract] [Full Text] [Related]

  • 5. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs.
    Efendic S, Alvarsson M, Brismar K, Wagner H.
    Acta Physiol (Oxf); 2008 Jan 13; 192(1):117-25. PubMed ID: 18171434
    [Abstract] [Full Text] [Related]

  • 6. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P.
    Diabetes Obes Metab; 2008 Dec 13; 10(12):1167-77. PubMed ID: 18494804
    [Abstract] [Full Text] [Related]

  • 7. Management of type 2 diabetes: oral agents, insulin, and injectables.
    Fonseca VA, Kulkarni KD.
    J Am Diet Assoc; 2008 Apr 13; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
    [Abstract] [Full Text] [Related]

  • 8. Treating non-insulin-dependent diabetes. Oral agents or insulin?
    Shlossberg AH.
    Can Fam Physician; 1993 Jan 13; 39():119-20, 123-6. PubMed ID: 8435549
    [Abstract] [Full Text] [Related]

  • 9. Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions.
    Dagogo-Jack S, Santiago JV.
    Arch Intern Med; 1997 Sep 08; 157(16):1802-17. PubMed ID: 9290539
    [Abstract] [Full Text] [Related]

  • 10. The stepwise approach to the management of type 2 diabetes.
    Warren RE.
    Diabetes Res Clin Pract; 2004 Sep 08; 65 Suppl 1():S3-8. PubMed ID: 15315864
    [Abstract] [Full Text] [Related]

  • 11. Protection of pancreatic beta-cells: is it feasible?
    Bonora E.
    Nutr Metab Cardiovasc Dis; 2008 Jan 08; 18(1):74-83. PubMed ID: 18096375
    [Abstract] [Full Text] [Related]

  • 12. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA, Nathan MS, Beattie P.
    Ann Emerg Med; 2001 Jul 08; 38(1):68-78. PubMed ID: 11423816
    [Abstract] [Full Text] [Related]

  • 13. Insulin therapy and exercise.
    Kourtoglou GI.
    Diabetes Res Clin Pract; 2011 Aug 08; 93 Suppl 1():S73-7. PubMed ID: 21864755
    [Abstract] [Full Text] [Related]

  • 14. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
    Yang W, Ji Q, Zhu D, Yang J, Chen L, Liu Z, Yu D, Yan L.
    Diabetes Care; 2008 May 08; 31(5):852-6. PubMed ID: 18268073
    [Abstract] [Full Text] [Related]

  • 15. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA, Kane MP, Busch RS.
    Pharmacotherapy; 2007 Oct 08; 27(10):1449-55. PubMed ID: 17896900
    [Abstract] [Full Text] [Related]

  • 16. Perioperative management of ambulatory surgical patients with diabetes mellitus.
    Vann MA.
    Curr Opin Anaesthesiol; 2009 Dec 08; 22(6):718-24. PubMed ID: 19696663
    [Abstract] [Full Text] [Related]

  • 17. Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents.
    Home PD, Pacini G.
    Diabetes Obes Metab; 2008 Sep 08; 10(9):699-718. PubMed ID: 17825080
    [Abstract] [Full Text] [Related]

  • 18. The pathogenesis of insulin resistance in children: metabolic complications and the roles of diet, exercise and pharmacotherapy in the prevention of type 2 diabetes.
    Artz E, Freemark M.
    Pediatr Endocrinol Rev; 2004 Mar 08; 1(3):296-309. PubMed ID: 16437023
    [Abstract] [Full Text] [Related]

  • 19. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun 08; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 20. Treatment of type 2 diabetes mellitus.
    Florence JA, Yeager BF.
    Am Fam Physician; 1999 May 15; 59(10):2835-44, 2849-50. PubMed ID: 10348076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.